Navigation Links
Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool
Date:11/4/2009

Real-time in situ FTIR analysis has become a standard tool in the chemical and pharmaceutical industries for providing information rich data that allows a more thorough understanding of reactions during the development and scale-up of chemical processes. METTLER TOLEDO is offering a free webinar discussing the Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool on November 11, 2009.

Columbia, MD (PRWEB) November 4, 2009 -- METTLER TOLEDO recently announced that it will host a free webinar Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool on November 11, 2009. Real-time in situ FTIR analysis has become a standard tool in the chemical and pharmaceutical industries for providing information rich data that allows a more thorough understanding of reactions during the development and scale-up of chemical processes.

This webinar will use several case studies from recent literature to illustrate how real-time mid-infrared data was used to provide valuable information that resulted in more efficient chemical development. The case studies include:

 
  • Conversion of a batch process to continuous flow process
  • Role of Process Analytical Technologies (PAT) in defining a manufacturing process of an Active Pharmaceutical Ingredient (API)
  • In situ data provides critical information about the source of process variability
This webinar will be helpful to Chemists and Chemical Engineers working in batch processing, continuous processing, or continuous chemistry in the Pharmaceutical and Chemical industries.

###

Read the full story at http://www.prweb.com/releases/chemical/processes/prweb3149614.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Laureate Pharma Welcomes Three New Members to Business Development Team
2. BioWa and NKTT Announce Licensing of BioWas POTELLIGENT(R) Technology For Use in Antibody Research and Development
3. Monsanto and Huazhong Agricultural University Enter Into Collaboration Focusing on Development of Plant Biotechnology
4. GreenHouse and Allard Research and Development Partner to Revolutionize Large-Scale Ethanol Fuel Systems
5. Jeremy M. Stipkala to Lead Symposium Entitled Patent Law Developments at SERMACS 2009
6. goBalto Introduces Web-based Solution to Manage Drug-development Collaborations
7. 17th International Process Development Conference to Feature Presentations on Safety, Process Development, Crystallization, PAT, Scale-Up and Production
8. Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist
9. Calibration Free Supersaturation Assessment and Control for the Development and Optimization of Crystallization Processes
10. Cryo-Cell Internationals Stem Cell Research and Development Helps the Fight Against Breast Cancer
11. YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool 
(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
Breaking Biology Technology:
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):